Enhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of “Reduce” from Brokerages

Enhabit, Inc. (NYSE:EHAB) has received a consensus recommendation of “Reduce” from the seven analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating and six have given a hold rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $9.35.

Separately, Bank of America dropped their price objective on shares of Enhabit from $9.00 to $8.00 and set an “underperform” rating on the stock in a research note on Thursday, June 27th.

Enhabit Price Performance

Shares of NYSE:EHAB opened at $8.05 on Friday. The company’s fifty day moving average is $8.75 and its two-hundred day moving average is $9.37. The company has a market cap of $403.76 million, a P/E ratio of -4.85 and a beta of 1.82. Enhabit has a 12-month low of $7.12 and a 12-month high of $12.19. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.73.

Enhabit (NYSE:EHAB) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.02. The firm had revenue of $260.60 million during the quarter, compared to analyst estimates of $265.99 million. Enhabit had a positive return on equity of 1.61% and a negative net margin of 0.84%. During the same period last year, the company posted $0.04 EPS. Equities analysts expect that Enhabit will post 0.26 earnings per share for the current fiscal year.

Insider Activity at Enhabit

In other Enhabit news, Director Jeffrey Bolton purchased 5,000 shares of the company’s stock in a transaction dated Thursday, August 22nd. The shares were bought at an average price of $8.01 per share, for a total transaction of $40,050.00. Following the purchase, the director now directly owns 78,877 shares in the company, valued at approximately $631,804.77. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.90% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in EHAB. Gladius Capital Management LP acquired a new position in Enhabit during the second quarter valued at approximately $31,000. Quarry LP grew its stake in Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after buying an additional 2,621 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new position in Enhabit in the 1st quarter worth $44,000. ProShare Advisors LLC acquired a new position in Enhabit during the 1st quarter worth $118,000. Finally, Canada Pension Plan Investment Board bought a new stake in Enhabit during the second quarter valued at about $93,000.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.